サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1645725

医薬品座薬の世界市場：タイプ別、基剤別、処方タイプ別、治療用途別、充填量カテゴリー別、年齢層別、流通チャネル別、エンドユーザー別 - 機会分析と産業予測、2024年～2035年

Pharmaceutical Suppositories Market By Type, By Base, By Prescription Type, By Therapeutic Application, By Fill Volume Categories, By Age Group, By Distribution Channel, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035

出版日
ページ情報
英文 423 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医薬品座薬の世界市場：タイプ別、基剤別、処方タイプ別、治療用途別、充填量カテゴリー別、年齢層別、流通チャネル別、エンドユーザー別 - 機会分析と産業予測、2024年～2035年
出版日: 2024年12月01日
発行: Allied Market Research
ページ情報: 英文 423 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医薬品座薬市場は、2023年には16億6,809万米ドルとなり、2024年から2035年までのCAGRは5.7％を示し、2035年までには32億3,932万米ドルに達すると推定されます。

Pharmaceutical Suppositories Market-IMG1

医薬品座薬は、体腔に挿入するために設計された固形剤形であり、そこで溶解または溶融して有効成分を放出します。一般的には、ココアバター、グリセリン化ゼラチン、ポリエチレングリコール（PEG）などの基材を使用して製剤化され、安定性を提供し、薬物放出の制御を可能にします。製造工程では、基剤を溶かし、医薬品有効成分（API）および必要な賦形剤と混合し、混合物を所望の形状に成形します。冷却後、坐剤は固化し、使用するために包装されます。座薬は粘膜吸収によって薬剤を送達するように設計されています。

医薬品座薬市場は、いくつかの重要な要因によって成長しています。高齢者は錠剤を飲み込むのに苦労したり、局所的なドラッグデリバリーを必要とすることが多いためです。さらに、胃腸障害や特定のがんなどの慢性疾患の有病率が上昇しているため、座薬が提供できる標的治療のニーズが高まっています。ドラッグデリバリーのさらなる進歩により、座薬で投与される薬剤の範囲が拡大し、その有効性が高まっています。例えば、2023年にNational Library of Medicineによって発表された研究では、直腸経路で投与されたアジスロマイシン坐剤は、小児集団において経口投与と比較した場合、バイオアベイラビリティが有意に増加したことが示されています。さらに、早期診断を促進する政府の取り組みや、座薬の利点に対する一般市民の認識を高めるための製薬会社の取り組みが、市場の成長をさらに後押ししています。

しかし、市場拡大の妨げとなる課題もあります。溶解性の問題により、すべての薬剤が座薬を通じて安定的に、あるいは効果的に送達されるわけではないため、薬剤の適合性が限られていることが依然として問題となっています。さらに、複雑な製造工程には特殊な装置が必要であるため、製造コストが上昇し、製造業者の数も限られています。これらの要因により、市場へのアクセスが制限され、コストが高くなり、全体的な値ごろ感に影響を与えます。このような課題にもかかわらず、座薬の需要は、ドラッグデリバリーにおける独自の利点に後押しされて上昇を続けています。

医薬品座薬市場は、タイプ、基剤、処方タイプ、治療用途、充填量カテゴリー、年齢層、成分タイプ、流通チャネル、地域に区分されます。タイプ別では、市場は直腸座薬、膣座薬、尿道座薬に分けられます。基剤別では、脂肪性基剤、水混和性基剤、乳化性基剤に分類されます。水混和性基剤はさらに、グリセロゼラチン基剤、石鹸グリセリン坐剤、ポリエチレングリコール基剤に区分されます。乳化性基剤はさらに、ウィテプゾール、マッサエステリウム、マッサポールに区分されます。処方タイプに基づくと、OTC座薬と処方座薬に二分されます。治療用途ベースでは、鎮痛・抗炎症薬、制吐薬、下剤、ホルモン療法、抗真菌・抗菌薬、その他に分類されます。充填量のカテゴリー別では、小充填量、中充填量、大充填量に分けられます。年齢層別では、小児用と成人用に分けられます。成分タイプにより、原薬と賦形剤に分類されます。流通チャネル別では、病院薬局、小売薬局、オンライン販売に分けられます。エンドユーザー別では、病院・診療所、在宅医療、その他に分類されます。地域別では、市場は北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカで分析されます。

利害関係者にとっての主なメリット

  • 当レポートでは、2023年から2035年までの医薬品座薬市場分析の市場セグメント、現在の動向、推定・力学を定量的に分析し、医薬品座薬市場の有力な機会を特定します。
  • 市場促進要因、市場抑制要因、市場機会に関連する情報とともに市場調査を提供します。
  • ポーターのファイブフォース分析では、利害関係者が利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるよう、バイヤーとサプライヤーの力を強調します。
  • 医薬品座薬市場の細分化に関する詳細な分析は、市場機会を決定するのに役立ちます。
  • 各地域の主要国は、世界市場への収益貢献度に応じてマッピングされています。
  • 市場企業のポジショニングはベンチマーキングを容易にし、市場企業の現在のポジションを明確に理解することができます。
  • 本レポートには、地域別および世界の医薬品座薬市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析が含まれています。

本レポートで可能なカスタマイズ（追加費用とスケジュールが必要です。）

  • 顧客の関心に応じた企業プロファイルの追加
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 輸出入分析/データ

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主要な調査結果
    • 主要な影響要因
    • 主要な投資機会
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
      • 急性および慢性疾患の有病率の上昇
      • 高齢者人口の増加
      • 座薬の使用に関する認識と教育への取り組みの増加
    • 抑制要因
      • 医薬品座薬の製造の複雑さ
      • 座薬の保管と安定性の問題
    • 機会
      • 製剤技術の進歩

第4章 医薬品座薬市場：タイプ別

  • 概要
  • 直腸坐剤
  • 膣坐剤

第5章 医薬品座薬市場：基剤別

  • 概要
  • 脂肪塩基
  • 水混和性基剤
    • 水混和性基剤の医薬品座薬市場：タイプ別
  • 乳化性基剤
    • 乳化性基剤の医薬品座薬市場：タイプ別

第6章 医薬品座薬市場：処方タイプ別

  • 概要
  • 一般用医薬品
  • 処方坐剤

第7章 医薬品座薬市場：治療用途別

  • 概要
  • 鎮痛薬・抗炎症薬
  • 制吐剤
  • 緩下剤
  • ホルモン療法
  • 抗真菌薬・抗菌薬
  • その他

第8章 医薬品座薬市場：充填量カテゴリー別

  • 概要
  • 小容量充填剤
  • 中容量充填剤
  • 大容量充填剤

第9章 医薬品座薬市場：年齢層別

  • 概要
  • 小児用
  • 成人用

第10章 医薬品座薬市場：流通チャネル別

  • 概要
  • 病院薬局
  • ドラッグストア・小売薬局
  • オンラインプロバイダー

第11章 医薬品座薬市場：エンドユーザー別

  • 概要
  • 病院・診療所
  • 在宅医療
  • その他

第12章 医薬品座薬市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他
  • ラテンアメリカ
    • ラテンアメリカ
    • 中東・アフリカ

第13章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング、2023年

第14章 企業プロファイル

  • Intas Pharmaceuticals Ltd.
  • Pfizer Inc.
  • Church & Dwight Co. Inc.
  • Zydus Lifesciences Limited
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Bliss GVS Pharma Ltd
  • Bausch Health Companies Inc.
  • Cosette Pharmaceuticals, Inc.
目次
Product Code: A12350

The pharmaceutical suppositories market was valued for $1,668.09 million in 2023 and is estimated to reach $3,239.32 million by 2035, exhibiting a CAGR of 5.7% from 2024 to 2035.

Pharmaceutical Suppositories Market - IMG1

Pharmaceutical suppositories are solid dosage forms designed for insertion into body cavities, where they dissolve or melt to release active ingredients. They are commonly formulated using a base material such as cocoa butter, glycerinated gelatin, or polyethylene glycol (PEG) and others, which provides stability and enables controlled drug release. The manufacturing process involves melting the base, mixing it with the active pharmaceutical ingredient (API) and any necessary excipients, and then molding the mixture into the desired shape. Once cooled, the suppositories solidify and are packaged for use. Suppositories are designed to deliver medication via mucosal absorption.

The pharmaceutical suppositories market is growing due to several key factors. The aging global population is driving demand, as elderly individuals often struggle with swallowing pills or require localized drug delivery. Additionally, the rising prevalence of chronic diseases like gastrointestinal disorders and certain cancers increases the need for targeted treatments that suppositories can provide. Further advancements in drug delivery have expanded the range of medications administered via suppositories, enhancing their effectiveness. For instance, a study published by National Library of Medicine in 2023, stated that, an azithromycin suppository administered through the rectal route demonstrated significantly increased bioavailability when compared with oral administration in pediatric population. Moreover, government initiatives promoting early diagnosis, along with pharmaceutical companies' efforts to raise public awareness of suppository benefits, further support market growth.

However, certain challenges hinder market expansion. Limited drug compatibility remains an issue, as not all medications are stable or effectively delivered through suppositories due to solubility concerns. Moreover, the complex manufacturing processes require specialized equipment, which increases production costs and limits the number of manufacturers. These factors contribute to restricted market accessibility and higher costs, impacting overall affordability. Despite these challenges, the demand for suppositories continues to rise, driven by their unique advantages in drug delivery.

The pharmaceutical suppositories market is segmented into type, base, prescription type, therapeutic application, fill volume categories, age group, ingredient type, distribution channel, and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. According to base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of therapeutic application, it is categorized into analgesics and anti-inflammatory drugs, antiemetics, laxatives, hormonal therapies, antifungals and antibacterials, and others. As per fill volume categories, it is divided into small fill volumes, medium fill volumes, and large fill volumes. On the basis of age group, it is bifurcated into pediatric use, and adult use. Depending on ingredient type, it is classified into active pharmaceutical ingredients, and excipients. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, the market is categorized into hospitals and clinics, home care, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major players that operate in the pharmaceutical suppositories market include Zydus group, Bayer AG, Church & Dwight Co. Inc, Cosette Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., Sanofi S.A, Bliss GVS Pharma Ltd, and Bausch Health Companies Inc. The key players have adopted strategies such as product approval to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical suppositories market analysis from 2023 to 2035 to identify the prevailing pharmaceutical suppositories market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pharmaceutical suppositories market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pharmaceutical suppositories market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Import Export Analysis/Data

Key Market Segments

By Prescription Type

  • OTC
  • Prescribed Suppositories

By Therapeutic Application

  • Analgesics and Anti-Inflammatory Drugs
  • Antiemetics
  • Laxatives
  • Hormonal Therapies
  • Antifungals and Antibacterials
  • Others

By Fill Volume Categories

  • Small Fill Volumes
  • Medium Fill Volumes
  • Large Fill Volumes

By Type

  • Rectal Suppositories
  • Vaginal Suppositories

By Age Group

  • Pediatric Use
  • Adult Use

By Base

  • Fatty Bases
  • Water Miscible Base
    • Type
    • Glycero Gelatin Base
    • Soap Glycerin Suppositories
    • Polyethylene Glycol Bases
  • Emulsifying Bases
    • Type
    • Witepsol
    • Massa Esterium
    • Massuppol

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

By End User

  • Hospitals and Clinics
  • Home Care
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East And Africa

Key Market Players:

    • Bausch Health Companies Inc.
    • Bayer AG
    • Bliss GVS Pharma Ltd
    • Church & Dwight Co. Inc.
    • Cosette Pharmaceuticals, Inc.
    • Intas Pharmaceuticals Ltd.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Zydus Lifesciences Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of acute & chronic disorders
      • 3.4.1.2. Increase in the geriatric population
      • 3.4.1.3. Increase in initiatives for awareness and education for use of suppositories
    • 3.4.2. Restraints
      • 3.4.2.1. Manufacturing complexities of pharmaceutical suppositories
      • 3.4.2.2. Storage and stability issues of pharmaceutical suppositories
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancements in formulation technology

CHAPTER 4: PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Rectal Suppositories
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Vaginal Suppositories
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Fatty Bases
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Water Miscible Base
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
    • 5.3.4. Water Miscible Base Pharmaceutical Suppositories Market by Type
  • 5.4. Emulsifying Bases
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
    • 5.4.4. Emulsifying Bases Pharmaceutical Suppositories Market by Type

CHAPTER 6: PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. OTC
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Prescribed Suppositories
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Analgesics and Anti-Inflammatory Drugs
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Antiemetics
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Laxatives
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Hormonal Therapies
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country
  • 7.6. Antifungals and Antibacterials
    • 7.6.1. Key market trends, growth factors and opportunities
    • 7.6.2. Market size and forecast, by region
    • 7.6.3. Market share analysis by country
  • 7.7. Others
    • 7.7.1. Key market trends, growth factors and opportunities
    • 7.7.2. Market size and forecast, by region
    • 7.7.3. Market share analysis by country

CHAPTER 8: PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. Small Fill Volumes
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by region
    • 8.2.3. Market share analysis by country
  • 8.3. Medium Fill Volumes
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by region
    • 8.3.3. Market share analysis by country
  • 8.4. Large Fill Volumes
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by region
    • 8.4.3. Market share analysis by country

CHAPTER 9: PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP

  • 9.1. Overview
    • 9.1.1. Market size and forecast
  • 9.2. Pediatric Use
    • 9.2.1. Key market trends, growth factors and opportunities
    • 9.2.2. Market size and forecast, by region
    • 9.2.3. Market share analysis by country
  • 9.3. Adult Use
    • 9.3.1. Key market trends, growth factors and opportunities
    • 9.3.2. Market size and forecast, by region
    • 9.3.3. Market share analysis by country

CHAPTER 10: PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL

  • 10.1. Overview
    • 10.1.1. Market size and forecast
  • 10.2. Hospital Pharmacies
    • 10.2.1. Key market trends, growth factors and opportunities
    • 10.2.2. Market size and forecast, by region
    • 10.2.3. Market share analysis by country
  • 10.3. Drug Stores and Retail Pharmacies
    • 10.3.1. Key market trends, growth factors and opportunities
    • 10.3.2. Market size and forecast, by region
    • 10.3.3. Market share analysis by country
  • 10.4. Online Providers
    • 10.4.1. Key market trends, growth factors and opportunities
    • 10.4.2. Market size and forecast, by region
    • 10.4.3. Market share analysis by country

CHAPTER 11: PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER

  • 11.1. Overview
    • 11.1.1. Market size and forecast
  • 11.2. Hospitals and Clinics
    • 11.2.1. Key market trends, growth factors and opportunities
    • 11.2.2. Market size and forecast, by region
    • 11.2.3. Market share analysis by country
  • 11.3. Home Care
    • 11.3.1. Key market trends, growth factors and opportunities
    • 11.3.2. Market size and forecast, by region
    • 11.3.3. Market share analysis by country
  • 11.4. Others
    • 11.4.1. Key market trends, growth factors and opportunities
    • 11.4.2. Market size and forecast, by region
    • 11.4.3. Market share analysis by country

CHAPTER 12: PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION

  • 12.1. Overview
    • 12.1.1. Market size and forecast By Region
  • 12.2. North America
    • 12.2.1. Key market trends, growth factors and opportunities
    • 12.2.2. Market size and forecast, by Type
    • 12.2.3. Market size and forecast, by Base
    • 12.2.4. Market size and forecast, by Prescription Type
    • 12.2.5. Market size and forecast, by Therapeutic Application
    • 12.2.6. Market size and forecast, by Fill Volume Categories
    • 12.2.7. Market size and forecast, by Age Group
    • 12.2.8. Market size and forecast, by Distribution Channel
    • 12.2.9. Market size and forecast, by End User
    • 12.2.10. Market size and forecast, by country
      • 12.2.10.1. U.S.
      • 12.2.10.1.1. Market size and forecast, by Type
      • 12.2.10.1.2. Market size and forecast, by Base
      • 12.2.10.1.3. Market size and forecast, by Prescription Type
      • 12.2.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.2.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.2.10.1.6. Market size and forecast, by Age Group
      • 12.2.10.1.7. Market size and forecast, by Distribution Channel
      • 12.2.10.1.8. Market size and forecast, by End User
      • 12.2.10.2. Canada
      • 12.2.10.2.1. Market size and forecast, by Type
      • 12.2.10.2.2. Market size and forecast, by Base
      • 12.2.10.2.3. Market size and forecast, by Prescription Type
      • 12.2.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.2.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.2.10.2.6. Market size and forecast, by Age Group
      • 12.2.10.2.7. Market size and forecast, by Distribution Channel
      • 12.2.10.2.8. Market size and forecast, by End User
      • 12.2.10.3. Mexico
      • 12.2.10.3.1. Market size and forecast, by Type
      • 12.2.10.3.2. Market size and forecast, by Base
      • 12.2.10.3.3. Market size and forecast, by Prescription Type
      • 12.2.10.3.4. Market size and forecast, by Therapeutic Application
      • 12.2.10.3.5. Market size and forecast, by Fill Volume Categories
      • 12.2.10.3.6. Market size and forecast, by Age Group
      • 12.2.10.3.7. Market size and forecast, by Distribution Channel
      • 12.2.10.3.8. Market size and forecast, by End User
  • 12.3. Europe
    • 12.3.1. Key market trends, growth factors and opportunities
    • 12.3.2. Market size and forecast, by Type
    • 12.3.3. Market size and forecast, by Base
    • 12.3.4. Market size and forecast, by Prescription Type
    • 12.3.5. Market size and forecast, by Therapeutic Application
    • 12.3.6. Market size and forecast, by Fill Volume Categories
    • 12.3.7. Market size and forecast, by Age Group
    • 12.3.8. Market size and forecast, by Distribution Channel
    • 12.3.9. Market size and forecast, by End User
    • 12.3.10. Market size and forecast, by country
      • 12.3.10.1. Germany
      • 12.3.10.1.1. Market size and forecast, by Type
      • 12.3.10.1.2. Market size and forecast, by Base
      • 12.3.10.1.3. Market size and forecast, by Prescription Type
      • 12.3.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.1.6. Market size and forecast, by Age Group
      • 12.3.10.1.7. Market size and forecast, by Distribution Channel
      • 12.3.10.1.8. Market size and forecast, by End User
      • 12.3.10.2. France
      • 12.3.10.2.1. Market size and forecast, by Type
      • 12.3.10.2.2. Market size and forecast, by Base
      • 12.3.10.2.3. Market size and forecast, by Prescription Type
      • 12.3.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.2.6. Market size and forecast, by Age Group
      • 12.3.10.2.7. Market size and forecast, by Distribution Channel
      • 12.3.10.2.8. Market size and forecast, by End User
      • 12.3.10.3. UK
      • 12.3.10.3.1. Market size and forecast, by Type
      • 12.3.10.3.2. Market size and forecast, by Base
      • 12.3.10.3.3. Market size and forecast, by Prescription Type
      • 12.3.10.3.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.3.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.3.6. Market size and forecast, by Age Group
      • 12.3.10.3.7. Market size and forecast, by Distribution Channel
      • 12.3.10.3.8. Market size and forecast, by End User
      • 12.3.10.4. Rest of Europe
      • 12.3.10.4.1. Market size and forecast, by Type
      • 12.3.10.4.2. Market size and forecast, by Base
      • 12.3.10.4.3. Market size and forecast, by Prescription Type
      • 12.3.10.4.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.4.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.4.6. Market size and forecast, by Age Group
      • 12.3.10.4.7. Market size and forecast, by Distribution Channel
      • 12.3.10.4.8. Market size and forecast, by End User
  • 12.4. Asia-Pacific
    • 12.4.1. Key market trends, growth factors and opportunities
    • 12.4.2. Market size and forecast, by Type
    • 12.4.3. Market size and forecast, by Base
    • 12.4.4. Market size and forecast, by Prescription Type
    • 12.4.5. Market size and forecast, by Therapeutic Application
    • 12.4.6. Market size and forecast, by Fill Volume Categories
    • 12.4.7. Market size and forecast, by Age Group
    • 12.4.8. Market size and forecast, by Distribution Channel
    • 12.4.9. Market size and forecast, by End User
    • 12.4.10. Market size and forecast, by country
      • 12.4.10.1. Japan
      • 12.4.10.1.1. Market size and forecast, by Type
      • 12.4.10.1.2. Market size and forecast, by Base
      • 12.4.10.1.3. Market size and forecast, by Prescription Type
      • 12.4.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.1.6. Market size and forecast, by Age Group
      • 12.4.10.1.7. Market size and forecast, by Distribution Channel
      • 12.4.10.1.8. Market size and forecast, by End User
      • 12.4.10.2. China
      • 12.4.10.2.1. Market size and forecast, by Type
      • 12.4.10.2.2. Market size and forecast, by Base
      • 12.4.10.2.3. Market size and forecast, by Prescription Type
      • 12.4.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.2.6. Market size and forecast, by Age Group
      • 12.4.10.2.7. Market size and forecast, by Distribution Channel
      • 12.4.10.2.8. Market size and forecast, by End User
      • 12.4.10.3. India
      • 12.4.10.3.1. Market size and forecast, by Type
      • 12.4.10.3.2. Market size and forecast, by Base
      • 12.4.10.3.3. Market size and forecast, by Prescription Type
      • 12.4.10.3.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.3.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.3.6. Market size and forecast, by Age Group
      • 12.4.10.3.7. Market size and forecast, by Distribution Channel
      • 12.4.10.3.8. Market size and forecast, by End User
      • 12.4.10.4. Rest of Asia-Pacific
      • 12.4.10.4.1. Market size and forecast, by Type
      • 12.4.10.4.2. Market size and forecast, by Base
      • 12.4.10.4.3. Market size and forecast, by Prescription Type
      • 12.4.10.4.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.4.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.4.6. Market size and forecast, by Age Group
      • 12.4.10.4.7. Market size and forecast, by Distribution Channel
      • 12.4.10.4.8. Market size and forecast, by End User
  • 12.5. LAMEA
    • 12.5.1. Key market trends, growth factors and opportunities
    • 12.5.2. Market size and forecast, by Type
    • 12.5.3. Market size and forecast, by Base
    • 12.5.4. Market size and forecast, by Prescription Type
    • 12.5.5. Market size and forecast, by Therapeutic Application
    • 12.5.6. Market size and forecast, by Fill Volume Categories
    • 12.5.7. Market size and forecast, by Age Group
    • 12.5.8. Market size and forecast, by Distribution Channel
    • 12.5.9. Market size and forecast, by End User
    • 12.5.10. Market size and forecast, by country
      • 12.5.10.1. Latin America
      • 12.5.10.1.1. Market size and forecast, by Type
      • 12.5.10.1.2. Market size and forecast, by Base
      • 12.5.10.1.3. Market size and forecast, by Prescription Type
      • 12.5.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.5.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.5.10.1.6. Market size and forecast, by Age Group
      • 12.5.10.1.7. Market size and forecast, by Distribution Channel
      • 12.5.10.1.8. Market size and forecast, by End User
      • 12.5.10.2. Middle East And Africa
      • 12.5.10.2.1. Market size and forecast, by Type
      • 12.5.10.2.2. Market size and forecast, by Base
      • 12.5.10.2.3. Market size and forecast, by Prescription Type
      • 12.5.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.5.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.5.10.2.6. Market size and forecast, by Age Group
      • 12.5.10.2.7. Market size and forecast, by Distribution Channel
      • 12.5.10.2.8. Market size and forecast, by End User

CHAPTER 13: COMPETITIVE LANDSCAPE

  • 13.1. Introduction
  • 13.2. Top winning strategies
  • 13.3. Product mapping of top 10 player
  • 13.4. Competitive dashboard
  • 13.5. Competitive heatmap
  • 13.6. Top player positioning, 2023

CHAPTER 14: COMPANY PROFILES

  • 14.1. Intas Pharmaceuticals Ltd.
    • 14.1.1. Company overview
    • 14.1.2. Key executives
    • 14.1.3. Company snapshot
    • 14.1.4. Operating business segments
    • 14.1.5. Product portfolio
  • 14.2. Pfizer Inc.
    • 14.2.1. Company overview
    • 14.2.2. Key executives
    • 14.2.3. Company snapshot
    • 14.2.4. Operating business segments
    • 14.2.5. Product portfolio
    • 14.2.6. Business performance
  • 14.3. Church & Dwight Co. Inc.
    • 14.3.1. Company overview
    • 14.3.2. Key executives
    • 14.3.3. Company snapshot
    • 14.3.4. Operating business segments
    • 14.3.5. Product portfolio
    • 14.3.6. Business performance
  • 14.4. Zydus Lifesciences Limited
    • 14.4.1. Company overview
    • 14.4.2. Key executives
    • 14.4.3. Company snapshot
    • 14.4.4. Operating business segments
    • 14.4.5. Product portfolio
    • 14.4.6. Business performance
    • 14.4.7. Key strategic moves and developments
  • 14.5. Bayer AG
    • 14.5.1. Company overview
    • 14.5.2. Key executives
    • 14.5.3. Company snapshot
    • 14.5.4. Operating business segments
    • 14.5.5. Product portfolio
    • 14.5.6. Business performance
  • 14.6. Novartis AG
    • 14.6.1. Company overview
    • 14.6.2. Key executives
    • 14.6.3. Company snapshot
    • 14.6.4. Operating business segments
    • 14.6.5. Product portfolio
    • 14.6.6. Business performance
  • 14.7. Sanofi S.A.
    • 14.7.1. Company overview
    • 14.7.2. Key executives
    • 14.7.3. Company snapshot
    • 14.7.4. Operating business segments
    • 14.7.5. Product portfolio
    • 14.7.6. Business performance
  • 14.8. Bliss GVS Pharma Ltd
    • 14.8.1. Company overview
    • 14.8.2. Key executives
    • 14.8.3. Company snapshot
    • 14.8.4. Operating business segments
    • 14.8.5. Product portfolio
    • 14.8.6. Business performance
  • 14.9. Bausch Health Companies Inc.
    • 14.9.1. Company overview
    • 14.9.2. Key executives
    • 14.9.3. Company snapshot
    • 14.9.4. Operating business segments
    • 14.9.5. Product portfolio
    • 14.9.6. Business performance
  • 14.10. Cosette Pharmaceuticals, Inc.
    • 14.10.1. Company overview
    • 14.10.2. Key executives
    • 14.10.3. Company snapshot
    • 14.10.4. Operating business segments
    • 14.10.5. Product portfolio